Rosen Law Firm has filed a securities class action lawsuit on behalf of investors who purchased American Depositary Shares (ADS) of Mereo BioPharma Group plc (NASDAQ: MREO) between June 5, 2023, and December 26, 2025. Investors interested in serving as lead plaintiff must submit their motion to the court by April 6, 2026.
The firm encourages affected shareholders to seek legal counsel promptly to protect their rights in this ongoing litigation.
**Why this matters**
The class action provides an opportunity for investors who purchased Mereo BioPharma ADS during the specified period to potentially recover losses related to alleged securities violations. Meeting the April 6 deadline is crucial for those wishing to take an active role in the case.
Source: NewsData